Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arbutus Berry - Intervention Study to Evaluate the Modulation of Intestinal Microbiota and Metabolic Parameters

NCT05810922 is registered in ClinicalTrials.gov with Universidade Nova de Lisboa as lead sponsor.

NCT NCT05810922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05810922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arbutus Berry - Intervention Study to Evaluate the Modulation of Intestinal Microbiota and Metabolic Parameters
Lead sponsor
Universidade Nova de Lisboa
Phase
Not applicable
Overall status
Completed
Start date
November 8, 2022
Completion date
December 22, 2022
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diet habit